Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Cadista Has Completed Its Recall Of Terazosin 5 mg Capsules
Cadista Pharmaceuticals, Inc has finished its recall of a single lot of Terazosin HCl Capsules, 5 mg. Lot number 9P050 was recalled because this lot may have been packaged with two dosage strengths of the same drug. Terazosin is commonly used in the treatment of high blood pressure and Benign Prostatic Hyperplasia (BPH)). It is also sold under the brand name Hytrin. This recall alert only applied to the single lot of the generic Terazosin 5 mg capsules from Cadista. No other Terazosin or Hytrin products were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm202904.htm
Learn More

Novartis Issues Recall Of Single Lot of Amlodipine/Benazepril Capsules at Warehouse/Retail Level
Novartis Pharmaceuticals Corp. is recalling a single lot of Amlodipine Besylate and Benazepril HCl Capsules, 5mg/10mg (equivalent to amlodipine 5 mg and benazepril 10 mg) made by Sandoz. Lot number F1031 is being recalled because routine testing of samples from this lot found one capsule that did not contain the Benazepril 10 mg tablet. Amlodipine Besylate and Benazepril HCl capsules are a combination capsule that is commonly used to control high blood pressure. It is also sold under the brand name Lotrel. This recall alert only applies to this single lot of Amlodipine Besylate and Benazepril HCl Capsules, 5mg/10mg from Novartis/Sandoz. No other amlodipine Besylate and Benazepril HCl 5mg/10mg capsules or Lotrel products are involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm202904.htm
Learn More

Date Published Title Drug Source
2010-03-16 Cadista Has Completed Its Recall Of Terazosin 5 mg Capsules Terazosin FDA
2010-03-16 Novartis Issues Recall Of Single Lot of Amlodipine/Benazepril Capsules at Warehouse/Retail Level FDA
2010-03-16 Paddock Recalls Select Lots of Compro Prochlorperazine Suppositories At Warehouse/Retail Level Prochlorperazine FDA
2010-03-15 FDA Makes Statement on the ACCORD Lipid Trial Fenofibrate FDA
2010-03-15 FDA Makes Statement on the ACCORD Lipid Trial Fenofibric Acid FDA
2010-03-12 FDA Adds Boxed Warning to Plavix (Clopidogrel) Clopidogrel FDA
2010-03-11 FDA Publishes Results of Ongoing Safety Review of Oral Bisphosphonates and Femur Fractures Alendronate FDA
2010-03-11 Black Box Warning for WinRho SDF Warns About Potentially Life Threatening Reaction WinRho SDF Manufacturer
2010-03-05 FDA Approves Name Change for Heartburn Drug Kapidex Dexlansoprazole FDA
2010-03-02 Wyeth Recalls Several Lots of Effexor XR 37.5 mg, 75 mg, and 150 mg Capsules Venlafaxine FDA
2010-03-01 Updated "Mifeprex Question and Answers" on FDA Website Mifepristone FDA
2010-03-01 LifeScan Recalls Eight Lots of OneTouch SureStep Test Strips Due To Falsely Low Readings Insulin Manufacturer
2010-02-23 The FDA Is Reviewing A Possible Safety Concern for HIV Drug Combination of INVIRASE with NORVIR Saquinavir FDA
2010-02-23 Ongoing Review of AVANDIA (ROSIGLITAZONE) and Cardiovascular Safety Rosiglitazone FDA
2010-02-19 Recall of Two Lots of PREMPRO 0.3 mg/1.5 mg EZ-DIAL Dispensers Estrogens Conjugated with Medroxyprogesterone FDA
2010-02-19 Recall of a Single Lot of Pilocarpine Hydrochloride 5 mg Tablets Pilocarpine FDA
2010-02-19 Recall of Four Lots of ANTIBACTERIAL WASHCLOTHS Containing Benzalkonium Chloride FDA
2010-02-18 Boxed Warning and Other Changes to the EXJADE Prescribing Information Deferasirox Manufacturer
2010-02-18 New Safety Requirements for Long-acting Inhaled Asthma Medications Called Long-Acting Beta-Agonists (LABAs) Formoterol with Budesonide FDA
2010-02-18 Product Confusion with Maalox Total Relief and Maalox Liquid Products Aluminium Hydroxide with Magnesium Hydroxide FDA